64 related articles for article (PubMed ID: 9389710)
21. Role of the CTCF Binding Site in Human T-Cell Leukemia Virus-1 Pathogenesis.
Joseph A; Cheng X; Harding J; Al-Saleem J; Green P; Veis D; Rauch D; Ratner L
bioRxiv; 2024 May; ():. PubMed ID: 38853836
[TBL] [Abstract][Full Text] [Related]
22. The PRMT5 inhibitor EPZ015666 is effective against HTLV-1-transformed T-cell lines
Ernzen K; Melvin C; Yu L; Phelps C; Niewiesk S; Green PL; Panfil AR
Front Microbiol; 2023; 14():1101544. PubMed ID: 36819050
[TBL] [Abstract][Full Text] [Related]
23. Induction of reactive oxygen species by human T-cell leukemia virus type 1 tax correlates with DNA damage and expression of cellular senescence marker.
Kinjo T; Ham-Terhune J; Peloponese JM; Jeang KT
J Virol; 2010 May; 84(10):5431-7. PubMed ID: 20219913
[TBL] [Abstract][Full Text] [Related]
24. The MHC-II transactivator CIITA, a restriction factor against oncogenic HTLV-1 and HTLV-2 retroviruses: similarities and differences in the inhibition of Tax-1 and Tax-2 viral transactivators.
Forlani G; Abdallah R; Accolla RS; Tosi G
Front Microbiol; 2013; 4():234. PubMed ID: 23986750
[TBL] [Abstract][Full Text] [Related]
25. Dynamics and consequences of the HTLV-1 proviral plus-strand burst.
Ramanayake S; Moulding DA; Tanaka Y; Singh A; Bangham CRM
PLoS Pathog; 2022 Nov; 18(11):e1010774. PubMed ID: 36441826
[TBL] [Abstract][Full Text] [Related]
26. CD30 stimulation induces multinucleation and chromosomal instability in HTLV-1-infected cell lines.
Watanabe M; Hatsuse H; Nagao K; Tanaka Y; Watanabe T; Horie R
Int J Hematol; 2023 Jul; 118(1):75-87. PubMed ID: 37014603
[TBL] [Abstract][Full Text] [Related]
27. Novel perspectives on antisense transcription in HIV-1, HTLV-1, and HTLV-2.
Lin E; Panfil AR; Sandel G; Jain P
Front Microbiol; 2022; 13():1042761. PubMed ID: 36620051
[TBL] [Abstract][Full Text] [Related]
28. Origin and functional role of antisense transcription in endogenous and exogenous retroviruses.
Romerio F
Retrovirology; 2023 May; 20(1):6. PubMed ID: 37194028
[TBL] [Abstract][Full Text] [Related]
29. "It's Only a Model": When Protein Structure Predictions Need Experimental Validation, the Case of the HTLV-1 Tax Protein.
Guillon C; Robert X; Gouet P
Pathogens; 2024 Mar; 13(3):. PubMed ID: 38535584
[TBL] [Abstract][Full Text] [Related]
30. HTLV-1 Extracellular Vesicles Promote Cell-to-Cell Contact.
Pinto DO; DeMarino C; Pleet ML; Cowen M; Branscome H; Al Sharif S; Jones J; Dutartre H; Lepene B; Liotta LA; Mahieux R; Kashanchi F
Front Microbiol; 2019; 10():2147. PubMed ID: 31620104
[TBL] [Abstract][Full Text] [Related]
31. Presence of Viral RNA and Proteins in Exosomes from Cellular Clones Resistant to Rift Valley Fever Virus Infection.
Ahsan NA; Sampey GC; Lepene B; Akpamagbo Y; Barclay RA; Iordanskiy S; Hakami RM; Kashanchi F
Front Microbiol; 2016; 7():139. PubMed ID: 26904012
[TBL] [Abstract][Full Text] [Related]
32. HTLV-1 proviruses encoding non-functional TAX in adult T-cell leukemia.
Okazaki S; Moriuchi R; Yosizuka N; Sugahara K; Maeda T; Jinnai I; Tomonaga M; Kamihira S; Katamine S
Virus Genes; 2001; 23(2):123-35. PubMed ID: 11724264
[TBL] [Abstract][Full Text] [Related]
33. Regulatory elements involved in tax-mediated transactivation of the HTLV-I LTR.
Seeler JS; Muchardt C; Podar M; Gaynor RB
Virology; 1993 Oct; 196(2):442-50. PubMed ID: 8372429
[TBL] [Abstract][Full Text] [Related]
34. Human T-cell lymphotropic/leukemia virus type 1 Tax abrogates p53-induced cell cycle arrest and apoptosis through its CREB/ATF functional domain.
Mulloy JC; Kislyakova T; Cereseto A; Casareto L; LoMonico A; Fullen J; Lorenzi MV; Cara A; Nicot C; Giam C; Franchini G
J Virol; 1998 Nov; 72(11):8852-60. PubMed ID: 9765430
[TBL] [Abstract][Full Text] [Related]
35. Functional inactivation of p53 by human T-cell leukemia virus type 1 Tax protein: mechanisms and clinical implications.
Tabakin-Fix Y; Azran I; Schavinky-Khrapunsky Y; Levy O; Aboud M
Carcinogenesis; 2006 Apr; 27(4):673-81. PubMed ID: 16308315
[TBL] [Abstract][Full Text] [Related]
36. Human T cell lymphotropic virus type I genomic expression and impact on intracellular signaling pathways during neurodegenerative disease and leukemia.
Yao J; Wigdahl B
Front Biosci; 2000 Jan; 5():D138-68. PubMed ID: 10702386
[TBL] [Abstract][Full Text] [Related]
37. Repression of transcription from the human T-cell leukemia virus type I long terminal repeat and cellular gene promoters by wild-type p53.
Mori N; Kashanchi F; Prager D
Blood; 1997 Dec; 90(12):4924-32. PubMed ID: 9389710
[TBL] [Abstract][Full Text] [Related]
38. Transactivation of the interleukin-1alpha promoter by human T-cell leukemia virus type I and type II Tax proteins.
Mori N; Prager D
Blood; 1996 Apr; 87(8):3410-7. PubMed ID: 8605359
[TBL] [Abstract][Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
